Neumora Therapeutics, Inc. Common Stock ( NMRA) - Stock Earnings
NMRA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
NMRA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -59.5 million USD | — USD |
| 2026Q1 | -53.5 million USD | — USD |
| 2026Q2 | -43.1 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NMRA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -235.9 million USD | — USD |
| 2024 | -243.8 million USD | — USD |
| 2025 | -236.9 million USD | — USD |
| 2026 Est. | — | — |
NMRA
Price: $0.46
52 week price:
Earnings Per Share: -1.23 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 86.8 million